Brazilian syphilis screening target puts Chembio agreement to the test
This article was originally published in Clinica
Brazil’s manufacturing agreement with diagnostics firm Chembio, and the supplies self-sufficiency drive it supports, is further being put to the test by new syphilis screening targets.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.